Zdrowie i gospodarka · 11/01/1999

FDA Approves Albendazole Suspension for Sheep Treatment

The US Food and Drug Administration (FDA) has amended its animal drug regulations to reflect the approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. for the use of 11.36% albendazole suspension in sheep, establishing a tolerance for drug residues in muscle and an acceptable daily intake (ADI).